Investor Due Diligence
Assessing a medical company for the purposes of venture capital due diligence or planning for fund raising requires in-depth knowledge of regulatory and clinical strategies, reimbursement, and quality systems in addition to other industry specific processes. RCRI knows medical devices, IVD's, and combination products and the strategy, processes, and timelines involved in moving from concept to commercialization.
RCRI can deploy a team of qualified experts in these functional areas to assist in your due diligence reviews. We can help you avoid surprises by asking the right questions early in the due diligence process, so you can prepare more accurate business assessments and valuations.
Regulatory Affairs and Clinical Trial Design & Management
RCRI understands the importance of regulatory and clinical strategies in a company's business model. We offer comprehensive global regulatory and clinical services and will apply that knowledge to your investment.
Reimbursement Planning
RCRI understands the importance of reimbursement to the ultimate financial success of a product. We know what is required to achieve optimal reimbursement. We also have the expertise to analyze available data in terms of generating outcomes and health economics arguments.
Quality Systems & Compliance
RCRI understands global quality and compliance requirements and has significant experience creating quality systems that comply with FDA regulations as well as those of the European Union, Japan, Canada, and Australia.